We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Process Validation Guidance Called Unnecessarily Burdensome
New Process Validation Guidance Called Unnecessarily Burdensome
March 2, 2009
Wyeth is contending that the FDA’s draft guidance on process validation would place an unnecessary burden on industry by recommending companies continue the same level of sampling and monitoring in the postmarket setting as they conducted when production processes were being qualified.